• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number T177
Device Problems High impedance (1291); Capturing Problem (2891)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/24/2017
Event Type  Injury  
Manufacturer Narrative
Additional information concerning the date of the revision procedure will be requested from the field.
 
Event Description
Boston scientific received information that this implantable cardioverter defibrillator (icd) and right ventricular (rv) lead exhibited high pacing threshold outputs and a high out of range shock impedance measurement of greater than 125 ohms.At this time no intervention has been performed and the icd remains in service.No adverse patient effects were reported.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Boston scientific received additional information that this patient was scheduled for a box change but instead the physician opted to deliver a 31 joule shock to test the system.The shock impedances were still observed to be greater than 125 ohms.At this time no further intervention has been performed and the system remains in service.No additional adverse patient effects were reported.
 
Event Description
Additional information noted that a recent interrogation showed a drop in shock impedance measurements which were no longer out of range.A request for further review was needed by boston scientific technical services (ts).Ts discuss that a disk data was needed to understand what the delivered shock impedance was, and what the daily measurements were doing.According to the field no further changes were made to the system and no cause for the drop in impedances was determined.The system remains in service.No adverse patient effects were reported.
 
Manufacturer Narrative
The icd is expected to be returned back from the field for analysis.This report will be updated upon completion of analysis.
 
Event Description
Additional information provided from the field indicated surgical intervention was performed and the implantable cardioverter defibrillator (icd) was explanted and replaced.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.A visual inspection of the device header and case noted no anomalies.Pin gauge testing, designed to verify proper port dimensions, was completed.Each port measured as expected.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITALITY 2
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key7191257
MDR Text Key97485522
Report Number2124215-2017-21315
Device Sequence Number1
Product Code KRG
Combination Product (y/n)N
Reporter Country CodeGB
PMA/PMN Number
P960040/S039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 09/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/19/2008
Device Model NumberT177
Other Device ID NumberVITALITY 2 VR EL
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2018
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received09/04/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/20/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-